img

Global Veterinary Peptide Products Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Veterinary Peptide Products Market Research Report 2024

According to MRAResearch’s new survey, global Veterinary Peptide Products market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Peptide Products market research.
Key companies engaged in the Veterinary Peptide Products industry include AmbioPharm, Zoetis, Ceva Corporate, Huvepharma, Lifecome Biochemistry, Qilu Pharmaceutical, Orion Animal Nutrition, Vega Pharma and Tianjin Xinxing Veterinary Pharmaceutical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Veterinary Peptide Products were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Veterinary Peptide Products market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Veterinary Peptide Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AmbioPharm
Zoetis
Ceva Corporate
Huvepharma
Lifecome Biochemistry
Qilu Pharmaceutical
Orion Animal Nutrition
Vega Pharma
Tianjin Xinxing Veterinary Pharmaceutical
Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
Segment by Type
Oxytocin
Gonadorelin
Buserelin
Veterinary Bacitracin Zinc
Others

Segment by Application


Pig
Ox
Sheep
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Veterinary Peptide Products report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Peptide Products Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oxytocin
1.2.3 Gonadorelin
1.2.4 Buserelin
1.2.5 Veterinary Bacitracin Zinc
1.2.6 Others
1.3 Market by Application
1.3.1 Global Veterinary Peptide Products Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pig
1.3.3 Ox
1.3.4 Sheep
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Peptide Products Market Perspective (2018-2033)
2.2 Veterinary Peptide Products Growth Trends by Region
2.2.1 Global Veterinary Peptide Products Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Veterinary Peptide Products Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Peptide Products Forecasted Market Size by Region (2024-2033)
2.3 Veterinary Peptide Products Market Dynamics
2.3.1 Veterinary Peptide Products Industry Trends
2.3.2 Veterinary Peptide Products Market Drivers
2.3.3 Veterinary Peptide Products Market Challenges
2.3.4 Veterinary Peptide Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Peptide Products Players by Revenue
3.1.1 Global Top Veterinary Peptide Products Players by Revenue (2018-2023)
3.1.2 Global Veterinary Peptide Products Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Peptide Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Peptide Products Revenue
3.4 Global Veterinary Peptide Products Market Concentration Ratio
3.4.1 Global Veterinary Peptide Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Peptide Products Revenue in 2022
3.5 Veterinary Peptide Products Key Players Head office and Area Served
3.6 Key Players Veterinary Peptide Products Product Solution and Service
3.7 Date of Enter into Veterinary Peptide Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Peptide Products Breakdown Data by Type
4.1 Global Veterinary Peptide Products Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Peptide Products Forecasted Market Size by Type (2024-2033)
5 Veterinary Peptide Products Breakdown Data by Application
5.1 Global Veterinary Peptide Products Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Peptide Products Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Veterinary Peptide Products Market Size (2018-2033)
6.2 North America Veterinary Peptide Products Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Veterinary Peptide Products Market Size by Country (2018-2023)
6.4 North America Veterinary Peptide Products Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Peptide Products Market Size (2018-2033)
7.2 Europe Veterinary Peptide Products Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Veterinary Peptide Products Market Size by Country (2018-2023)
7.4 Europe Veterinary Peptide Products Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Peptide Products Market Size (2018-2033)
8.2 Asia-Pacific Veterinary Peptide Products Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Veterinary Peptide Products Market Size by Region (2018-2023)
8.4 Asia-Pacific Veterinary Peptide Products Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Peptide Products Market Size (2018-2033)
9.2 Latin America Veterinary Peptide Products Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Veterinary Peptide Products Market Size by Country (2018-2023)
9.4 Latin America Veterinary Peptide Products Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Peptide Products Market Size (2018-2033)
10.2 Middle East & Africa Veterinary Peptide Products Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Veterinary Peptide Products Market Size by Country (2018-2023)
10.4 Middle East & Africa Veterinary Peptide Products Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AmbioPharm
11.1.1 AmbioPharm Company Detail
11.1.2 AmbioPharm Business Overview
11.1.3 AmbioPharm Veterinary Peptide Products Introduction
11.1.4 AmbioPharm Revenue in Veterinary Peptide Products Business (2018-2023)
11.1.5 AmbioPharm Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Veterinary Peptide Products Introduction
11.2.4 Zoetis Revenue in Veterinary Peptide Products Business (2018-2023)
11.2.5 Zoetis Recent Development
11.3 Ceva Corporate
11.3.1 Ceva Corporate Company Detail
11.3.2 Ceva Corporate Business Overview
11.3.3 Ceva Corporate Veterinary Peptide Products Introduction
11.3.4 Ceva Corporate Revenue in Veterinary Peptide Products Business (2018-2023)
11.3.5 Ceva Corporate Recent Development
11.4 Huvepharma
11.4.1 Huvepharma Company Detail
11.4.2 Huvepharma Business Overview
11.4.3 Huvepharma Veterinary Peptide Products Introduction
11.4.4 Huvepharma Revenue in Veterinary Peptide Products Business (2018-2023)
11.4.5 Huvepharma Recent Development
11.5 Lifecome Biochemistry
11.5.1 Lifecome Biochemistry Company Detail
11.5.2 Lifecome Biochemistry Business Overview
11.5.3 Lifecome Biochemistry Veterinary Peptide Products Introduction
11.5.4 Lifecome Biochemistry Revenue in Veterinary Peptide Products Business (2018-2023)
11.5.5 Lifecome Biochemistry Recent Development
11.6 Qilu Pharmaceutical
11.6.1 Qilu Pharmaceutical Company Detail
11.6.2 Qilu Pharmaceutical Business Overview
11.6.3 Qilu Pharmaceutical Veterinary Peptide Products Introduction
11.6.4 Qilu Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023)
11.6.5 Qilu Pharmaceutical Recent Development
11.7 Orion Animal Nutrition
11.7.1 Orion Animal Nutrition Company Detail
11.7.2 Orion Animal Nutrition Business Overview
11.7.3 Orion Animal Nutrition Veterinary Peptide Products Introduction
11.7.4 Orion Animal Nutrition Revenue in Veterinary Peptide Products Business (2018-2023)
11.7.5 Orion Animal Nutrition Recent Development
11.8 Vega Pharma
11.8.1 Vega Pharma Company Detail
11.8.2 Vega Pharma Business Overview
11.8.3 Vega Pharma Veterinary Peptide Products Introduction
11.8.4 Vega Pharma Revenue in Veterinary Peptide Products Business (2018-2023)
11.8.5 Vega Pharma Recent Development
11.9 Tianjin Xinxing Veterinary Pharmaceutical
11.9.1 Tianjin Xinxing Veterinary Pharmaceutical Company Detail
11.9.2 Tianjin Xinxing Veterinary Pharmaceutical Business Overview
11.9.3 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Introduction
11.9.4 Tianjin Xinxing Veterinary Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023)
11.9.5 Tianjin Xinxing Veterinary Pharmaceutical Recent Development
11.10 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
11.10.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Company Detail
11.10.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
11.10.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Introduction
11.10.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Revenue in Veterinary Peptide Products Business (2018-2023)
11.10.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Veterinary Peptide Products Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oxytocin
Table 3. Key Players of Gonadorelin
Table 4. Key Players of Buserelin
Table 5. Key Players of Veterinary Bacitracin Zinc
Table 6. Key Players of Others
Table 7. Global Veterinary Peptide Products Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Veterinary Peptide Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Veterinary Peptide Products Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Veterinary Peptide Products Market Share by Region (2018-2023)
Table 11. Global Veterinary Peptide Products Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Veterinary Peptide Products Market Share by Region (2024-2033)
Table 13. Veterinary Peptide Products Market Trends
Table 14. Veterinary Peptide Products Market Drivers
Table 15. Veterinary Peptide Products Market Challenges
Table 16. Veterinary Peptide Products Market Restraints
Table 17. Global Veterinary Peptide Products Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Veterinary Peptide Products Market Share by Players (2018-2023)
Table 19. Global Top Veterinary Peptide Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Peptide Products as of 2022)
Table 20. Ranking of Global Top Veterinary Peptide Products Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Veterinary Peptide Products Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Veterinary Peptide Products Product Solution and Service
Table 24. Date of Enter into Veterinary Peptide Products Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Veterinary Peptide Products Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Veterinary Peptide Products Revenue Market Share by Type (2018-2023)
Table 28. Global Veterinary Peptide Products Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Veterinary Peptide Products Revenue Market Share by Type (2024-2033)
Table 30. Global Veterinary Peptide Products Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Veterinary Peptide Products Revenue Market Share by Application (2018-2023)
Table 32. Global Veterinary Peptide Products Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Veterinary Peptide Products Revenue Market Share by Application (2024-2033)
Table 34. North America Veterinary Peptide Products Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Veterinary Peptide Products Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Veterinary Peptide Products Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Veterinary Peptide Products Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Veterinary Peptide Products Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Veterinary Peptide Products Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Veterinary Peptide Products Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Veterinary Peptide Products Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Veterinary Peptide Products Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Veterinary Peptide Products Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Veterinary Peptide Products Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Veterinary Peptide Products Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Veterinary Peptide Products Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Veterinary Peptide Products Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Veterinary Peptide Products Market Size by Country (2024-2033) & (US$ Million)
Table 49. AmbioPharm Company Detail
Table 50. AmbioPharm Business Overview
Table 51. AmbioPharm Veterinary Peptide Products Product
Table 52. AmbioPharm Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 53. AmbioPharm Recent Development
Table 54. Zoetis Company Detail
Table 55. Zoetis Business Overview
Table 56. Zoetis Veterinary Peptide Products Product
Table 57. Zoetis Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 58. Zoetis Recent Development
Table 59. Ceva Corporate Company Detail
Table 60. Ceva Corporate Business Overview
Table 61. Ceva Corporate Veterinary Peptide Products Product
Table 62. Ceva Corporate Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 63. Ceva Corporate Recent Development
Table 64. Huvepharma Company Detail
Table 65. Huvepharma Business Overview
Table 66. Huvepharma Veterinary Peptide Products Product
Table 67. Huvepharma Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 68. Huvepharma Recent Development
Table 69. Lifecome Biochemistry Company Detail
Table 70. Lifecome Biochemistry Business Overview
Table 71. Lifecome Biochemistry Veterinary Peptide Products Product
Table 72. Lifecome Biochemistry Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 73. Lifecome Biochemistry Recent Development
Table 74. Qilu Pharmaceutical Company Detail
Table 75. Qilu Pharmaceutical Business Overview
Table 76. Qilu Pharmaceutical Veterinary Peptide Products Product
Table 77. Qilu Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 78. Qilu Pharmaceutical Recent Development
Table 79. Orion Animal Nutrition Company Detail
Table 80. Orion Animal Nutrition Business Overview
Table 81. Orion Animal Nutrition Veterinary Peptide Products Product
Table 82. Orion Animal Nutrition Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 83. Orion Animal Nutrition Recent Development
Table 84. Vega Pharma Company Detail
Table 85. Vega Pharma Business Overview
Table 86. Vega Pharma Veterinary Peptide Products Product
Table 87. Vega Pharma Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 88. Vega Pharma Recent Development
Table 89. Tianjin Xinxing Veterinary Pharmaceutical Company Detail
Table 90. Tianjin Xinxing Veterinary Pharmaceutical Business Overview
Table 91. Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Product
Table 92. Tianjin Xinxing Veterinary Pharmaceutical Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 93. Tianjin Xinxing Veterinary Pharmaceutical Recent Development
Table 94. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Company Detail
Table 95. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
Table 96. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Product
Table 97. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Revenue in Veterinary Peptide Products Business (2018-2023) & (US$ Million)
Table 98. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Peptide Products Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Veterinary Peptide Products Market Share by Type: 2022 VS 2033
Figure 3. Oxytocin Features
Figure 4. Gonadorelin Features
Figure 5. Buserelin Features
Figure 6. Veterinary Bacitracin Zinc Features
Figure 7. Others Features
Figure 8. Global Veterinary Peptide Products Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Veterinary Peptide Products Market Share by Application: 2022 VS 2033
Figure 10. Pig Case Studies
Figure 11. Ox Case Studies
Figure 12. Sheep Case Studies
Figure 13. Others Case Studies
Figure 14. Veterinary Peptide Products Report Years Considered
Figure 15. Global Veterinary Peptide Products Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Veterinary Peptide Products Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Veterinary Peptide Products Market Share by Region: 2022 VS 2033
Figure 18. Global Veterinary Peptide Products Market Share by Players in 2022
Figure 19. Global Top Veterinary Peptide Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Peptide Products as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Veterinary Peptide Products Revenue in 2022
Figure 21. North America Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Veterinary Peptide Products Market Share by Country (2018-2033)
Figure 23. United States Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Veterinary Peptide Products Market Share by Country (2018-2033)
Figure 27. Germany Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Veterinary Peptide Products Market Share by Region (2018-2033)
Figure 35. China Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Veterinary Peptide Products Market Share by Country (2018-2033)
Figure 43. Mexico Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Veterinary Peptide Products Market Share by Country (2018-2033)
Figure 47. Turkey Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Veterinary Peptide Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. AmbioPharm Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 50. Zoetis Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 51. Ceva Corporate Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 52. Huvepharma Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 53. Lifecome Biochemistry Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 54. Qilu Pharmaceutical Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 55. Orion Animal Nutrition Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 56. Vega Pharma Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 57. Tianjin Xinxing Veterinary Pharmaceutical Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 58. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Revenue Growth Rate in Veterinary Peptide Products Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed